Prostate Adenocarcinoma Clinical Trials in Los Angeles, California

8 studies are recruiting for prostate adenocarcinoma in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a p…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    413 in total
    Run by
    NRG Oncology
  2. Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

    This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate cancer undergoing radical prostatectomy (RP) progressive disease. A total of 90 men will be accrued and randomized 1:1 to receive a 1000 mg dai…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    5 in total
    Run by
    National Cancer Institute (NCI)
  3. High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

    This phase II trial investigates the effect of high dose-rate brachytherapy and stereotactic body radiotherapy in treating patients with prostate adenocarcinoma. Brachytherapy, also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill tumor cel…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles, California
    Run by
    Jonsson Comprehensive Cancer Center
  4. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
    Locations
    341 in total
    Run by
    ECOG-ACRIN Cancer Research Group
  5. Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

    This is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomized 1:1 to receive the fasting mimicking diet, or usual diet. All patients will receive standard of care treatment for their prostate cancer.…

    Stage
    Phase 2
    Ages
    Any age
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    3 in total
    Run by
    Stephen Freedland
  6. A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

    To determine the effects of exercise therapy on molecular, radiologic, and pathologic nimbosus hallmarks versus usual care control in men on Active Surveillance for localized prostate cancer.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of California, Los Angeles (Data and Specimen Analysis Only), Los Angeles, California
    Locations
    10 in total
    Run by
    City of Hope Medical Center
  7. Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

    This phase II trial evaluates apalutamide in combination with image-guided stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate cancer. Prostate cancer usually needs the hormone testosterone to grow. Apalutamide is a hormone therapy that blocks the effect of testos…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
    Run by
    Jonsson Comprehensive Cancer Center
  8. Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

    This clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy. Although surgery a…

    Stage
    Not phased
    Ages
    40 and older
    Site
    UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
    Run by
    Jonsson Comprehensive Cancer Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.